Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma
This study has been withdrawn prior to enrollment.
(No patients were enrolled, study cancelled before start)
First Posted: May 23, 2003
Last Update Posted: October 19, 2016
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|